AIC
APLS

Archer Investment Corporation’s Apellis Pharmaceuticals APLS Stock Holding History

Archer Investment Corporation’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-500
Closed -$20.1K – 1212
2026
Q1 		$20.1K Hold
500
– – ﹤0.01% 678
2025
Q4 		$12.6K Hold
500
– – ﹤0.01% 687
2025
Q3 		$11.3K Hold
500
– – ﹤0.01% 713
2025
Q2 		$8.65K Hold
500
– – ﹤0.01% 730
2025
Q1 		$10.9K Hold
500
– – ﹤0.01% 674
2024
Q4 		$16K Hold
500
– – ﹤0.01% 615
2024
Q3 		$14.4K Hold
500
– – ﹤0.01% 621
2024
Q2 		$19.2K Hold
500
– – 0.01% 555
2024
Q1 		$29.4K Hold
500
– – 0.01% 480
2023
Q4 		$29.9K Hold
500
– – 0.01% 472
2023
Q3 		$19K Buy
+500
New +$22K 0.01% 515

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Archer Investment Corporation's APLS Position: Q2 2026 in Review

Archer Investment Corporation sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 500 shares — an estimated $20.1K sold.

Archer Investment Corporation first reported a position in APLS in Q3 2023 and held it in 11 quarters. The position peaked at $29.9K in Q4 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Archer Investment Corporation reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Archer Investment Corporation sold 500 Apellis Pharmaceuticals shares in Q2 2026, an estimated $20.1K.
  • Archer Investment Corporation first reported a position in Apellis Pharmaceuticals in Q3 2023 and held it in 11 quarters.
  • Archer Investment Corporation's Apellis Pharmaceuticals position peaked at $29.9K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.